Drugs / VRC-AVIDNA036-00-VP
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01086657 | Feb 2010 → Dec 2011 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00776711 | Oct 2008 → Jan 2011 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00489931 | Jun 2007 → Apr 2009 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00408109 | Dec 2006 → Aug 2008 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-AVIDNA036-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01086657 ↗ |
| Modality | Vaccine | “recombinant DNA vaccine” NCT00408109 ↗ |
| Route | Intramuscular | “administered intramuscularly (IM)” NCT00408109 ↗ |